Gadavist FDA Approval History
FDA Approved: Yes (First approved March 14, 2011)
Brand name: Gadavist
Generic name: gadobutrol
Dosage form: Injection
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Diagnosis and Investigation
Gadavist (gadobutrol) is a gadolinium-based contrast agent indicated for use in diagnostic magnetic resonance imaging (MRI).
Development timeline for Gadavist
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.